The pandemic of coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a serious global concern for public health with thousands of fatalities. Today, no specific drugs are available to treat this disease. Thus, there remains an urgent need for the development of specific antiviral therapeutics toward SARS-CoV-2.

Read more...